Omada Health growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +49.4%
EBITDA: +101.7%
EBIT: +75.5%
EPS: +83.1%
Free cash flow: +156.0%
Operating cash flow: +176.0%

Forward estimates

Revenue: +19.2%
EBITDA: —
EPS: +16.6%

Three-year CAGR

Revenue: +42.9%
EBITDA: +87.4%
EBIT: +72.6%
Net income: +72.9%
EPS: +74.1%
Free cash flow: +144.5%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.